LTL Pharma to License Dellegra AG to Nichi-Iko, Eyeing December Rollout

September 3, 2020
Nichi-Iko Pharmaceutical and LTL Pharma have entered into a license agreement for Pusofeki Combination Tablets “Sanik”, an authorized generic (AG) version of Sanofi’s anti-allergic medicine Dellegra (fexofenadine + pseudoephedrine), the companies said on September 1. Regarding generic versions of Dellegra,...read more